These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21169550)

  • 21. Glucocorticoid administration accelerates mortality of pneumovirus-infected mice.
    Domachowske JB; Bonville CA; Ali-Ahmad D; Dyer KD; Easton AJ; Rosenberg HF
    J Infect Dis; 2001 Dec; 184(12):1518-23. PubMed ID: 11740726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice.
    Ellis JA; Martin BV; Waldner C; Dyer KD; Domachowske JB; Rosenberg HF
    Vaccine; 2007 Jan; 25(6):1085-95. PubMed ID: 17052820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate immune protection from pneumonia virus of mice induced by a novel immunomodulator is prolonged by dual treatment and mediated by macrophages.
    Martinez EC; Garg R; van Drunen Littel-van den Hurk S
    Antiviral Res; 2019 Nov; 171():104594. PubMed ID: 31470041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6.
    Dyer KD; Percopo CM; Fischer ER; Gabryszewski SJ; Rosenberg HF
    Blood; 2009 Sep; 114(13):2649-56. PubMed ID: 19652202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activated mouse eosinophils protect against lethal respiratory virus infection.
    Percopo CM; Dyer KD; Ochkur SI; Luo JL; Fischer ER; Lee JJ; Lee NA; Domachowske JB; Rosenberg HF
    Blood; 2014 Jan; 123(5):743-52. PubMed ID: 24297871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent Airway Hyperresponsiveness Following Recovery from Infection with Pneumonia Virus of Mice.
    Limkar AR; Percopo CM; Redes JL; Druey KM; Rosenberg HF
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33922096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of proinflammatory cytokine genes in vivo in response to pathogenic and nonpathogenic pneumovirus infections.
    Domachowske JB; Bonville CA; Easton AJ; Rosenberg HF
    J Infect Dis; 2002 Jul; 186(1):8-14. PubMed ID: 12089656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The response of aged mice to primary infection and re-infection with pneumonia virus of mice depends on their genetic background.
    Shrivastava P; Watkiss E; van Drunen Littel-van den Hurk S
    Immunobiology; 2016 Mar; 221(3):494-502. PubMed ID: 26621546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-21 promotes the pathologic immune response to pneumovirus infection.
    Spolski R; Wang L; Wan CK; Bonville CA; Domachowske JB; Kim HP; Yu Z; Leonard WJ
    J Immunol; 2012 Feb; 188(4):1924-32. PubMed ID: 22238461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained inflammation and differential expression of interferons type I and III in PVM-infected interferon-gamma (IFNγ) gene-deleted mice.
    Glineur SF; Bowen AB; Percopo CM; Garcia-Crespo KE; Dyer KD; Ochkur SI; Lee NA; Lee JJ; Domachowske JB; Rosenberg HF
    Virology; 2014 Nov; 468-470():140-149. PubMed ID: 25173090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.
    Sheahan T; Morrison TE; Funkhouser W; Uematsu S; Akira S; Baric RS; Heise MT
    PLoS Pathog; 2008 Dec; 4(12):e1000240. PubMed ID: 19079579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innate and adaptive immune response to pneumonia virus of mice in a resistant and a susceptible mouse strain.
    Watkiss ER; Shrivastava P; Arsic N; Gomis S; van Drunen Littel-van den Hurk S
    Viruses; 2013 Jan; 5(1):295-320. PubMed ID: 23337382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Both nonstructural proteins NS1 and NS2 of pneumonia virus of mice are inhibitors of the interferon type I and type III responses in vivo.
    Heinze B; Frey S; Mordstein M; Schmitt-Gräff A; Ehl S; Buchholz UJ; Collins PL; Staeheli P; Krempl CD
    J Virol; 2011 May; 85(9):4071-84. PubMed ID: 21307191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptor 7 gene deficiency and early-life Pneumovirus infection interact to predispose toward the development of asthma-like pathology in mice.
    Kaiko GE; Loh Z; Spann K; Lynch JP; Lalwani A; Zheng Z; Davidson S; Uematsu S; Akira S; Hayball J; Diener KR; Baines KJ; Simpson JL; Foster PS; Phipps S
    J Allergy Clin Immunol; 2013 May; 131(5):1331-9.e10. PubMed ID: 23561801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion of nonstructural proteins NS1 and NS2 from pneumonia virus of mice attenuates viral replication and reduces pulmonary cytokine expression and disease.
    Buchholz UJ; Ward JM; Lamirande EW; Heinze B; Krempl CD; Collins PL
    J Virol; 2009 Feb; 83(4):1969-80. PubMed ID: 19052095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 28 days later: eosinophils stop viruses.
    Lacy P
    Blood; 2014 Jan; 123(5):609-11. PubMed ID: 24482499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Canine pneumovirus replicates in mouse lung tissue and elicits inflammatory pathology.
    Percopo CM; Dubovi EJ; Renshaw RW; Dyer KD; Domachowske JB; Rosenberg HF
    Virology; 2011 Jul; 416(1-2):26-31. PubMed ID: 21600624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pneumovirus-Induced Lung Disease in Mice Is Independent of Neutrophil-Driven Inflammation.
    Cortjens B; Lutter R; Boon L; Bem RA; van Woensel JB
    PLoS One; 2016; 11(12):e0168779. PubMed ID: 28005954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection.
    Domachowske JB; Bonville CA; Gao JL; Murphy PM; Easton AJ; Rosenberg HF
    J Immunol; 2000 Sep; 165(5):2677-82. PubMed ID: 10946298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo.
    Easton AJ; Scott PD; Edworthy NL; Meng B; Marriott AC; Dimmock NJ
    Vaccine; 2011 Mar; 29(15):2777-84. PubMed ID: 21320545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.